In 2024, 95% of adverse events associated with GLP-1s were related to either how the product was dosed or how it was administered, rather than issues with the drug
Asthma: Tell your doctor if you have asthma before using an inhaled form
This is the exception rather than the rule and requires careful patient selection, pre-peel barrier preparation, and post-peel monitoring
Westcott, who is yet to comment on the MHRA report, said in June that she had "never knowingly sold products containing undeclared ingredients".
Tirzepatide is aprescription-only injectable therapy provided exclusively within ASPNs clinician-guided programs
For most NI patients, private prescription through an online clinic has become the practical route to treatment